article thumbnail

Can J&J’s vaccine approval erase bad pharma?

World of DTC Marketing

SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Johnson & Johnson has paid $2.7 billion in penalties.

article thumbnail

Pharma’s climate change vulnerability and opportunity

pharmaphorum

Water-borne illnesses are also likely to become more common, as increased rain and storm surges contribute to flooding and contaminated run off. Just as in the wake of COVID-19, the world will look to pharma to fulfil its public health needs. Vulnerability . Making plans is not enough.

article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Furthermore, the number of marketed high potency APIs (HPAPIs) tends to increase over time as more HPAPIs in development gain approval.